$1.70M in average volume shows that Trevi Therapeutics Inc (TRVI) is heading in the right direction

On Monday, Trevi Therapeutics Inc (NASDAQ: TRVI) was 7.02% up from the session before settling in for the closing price of $6.55. A 52-week range for TRVI has been $2.36 – $7.48.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 27.09%. When this article was written, the company’s average yearly earnings per share was at 8.52%. With a float of $69.87 million, this company’s outstanding shares have now reached $99.89 million.

Considering the fact that the conglomerate employs 26 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.

Trevi Therapeutics Inc (TRVI) Insider Activity

Also, it is sometimes useful to examine the sentiment of large-scale investors toward Trevi Therapeutics Inc stocks. The insider ownership of Trevi Therapeutics Inc is 41.36%, while institutional ownership is 47.38%. The most recent insider transaction that took place on Mar 25 ’25, was worth 17,365. In this transaction Chief Scientific Officer of this company sold 2,631 shares at a rate of $6.60, taking the stock ownership to the 221,373 shares. Before that another transaction happened on Mar 21 ’25, when Company’s President & CEO sold 5,263 for $6.58, making the entire transaction worth $34,625. This insider now owns 213,313 shares in total.

Trevi Therapeutics Inc (TRVI) Earnings and Forecasts

According to the Wall Street analysts, stocks earnings will be around 8.52% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -12.29% during the next five years compared to 27.09% growth over the previous five years of trading.

Trevi Therapeutics Inc (NASDAQ: TRVI) Trading Performance Indicators

You can see what Trevi Therapeutics Inc (TRVI) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 15.38.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.45, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach -0.54 in one year’s time.

Technical Analysis of Trevi Therapeutics Inc (TRVI)

Compared to the last year’s volume of 1.84 million, its volume of 1.52 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 97.98%.

During the past 100 days, Trevi Therapeutics Inc’s (TRVI) raw stochastic average was set at 86.14%, which indicates a significant decrease from 98.77% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.33 in the past 14 days, which was lower than the 0.43 volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $6.28, while its 200-day Moving Average is $4.74. Nevertheless, the first resistance level for the watch stands at $7.19 in the near term. At $7.38, the stock is likely to face the second major resistance level. The third major resistance level sits at $7.72. If the price goes on to break the first support level at $6.66, it is likely to go to the next support level at $6.32. Should the price break the second support level, the third support level stands at $6.13.

Trevi Therapeutics Inc (NASDAQ: TRVI) Key Stats

There are 117,293K outstanding shares of the company, which has a market capitalization of 835.21 million. As of now, sales total 0 K while income totals -47,910 K. Its latest quarter income was 0 K while its last quarter net income were -10,340 K.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.